Although we don't know a lot about the causes of Alzheimer's disease, the following conditions may raise your risk.

GSK took center stage last month, forming standout partnerships and alliances across multiple therapeutic areas.

INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

Expected readouts in diabetes, cancer and depression headline a series of study results that could help the biotechnology ...

The Greater Pennsylvania chapter of the Alzheimer’s Association says it’s been a productive and exciting year when it comes ...

As a result, often by the time a person receives a diagnosis of Alzheimer’s disease, irreparable brain damage has already occurred. This makes intervention and treatment efforts very challenging. Our ...

Axsome Therapeutics (AXSM) stock fell 12% Monday after the company reported mixed Phase 3 results for its drug AXS-05 in the ...

Axsome Therapeutics said on Monday its experimental treatment for the Alzheimer's disease-related agitation met the main goal of a late-stage trial.

Axsome Therapeutics said it would submit its Alzheimer’s disease treatment for FDA approval despite mixed results from two ...

Researchers from Arizona State University and Banner Alzheimer’s Institute have discovered a surprising link between a common ...

Gene therapy is referred to as a medical technique that involves modifying or manipulating genes to treat or prevent disease.